7:30am Registration & Morning Coffee

8:20 am Chair’s Opening Remarks

  • AJ Bergman Chief Executive Officer , Capricor Therapeutics

Expanding the Therapeutic Applications with Emerging Non-Viral RNA Delivery Systems

8:30 am Breakfast Panel: What are Next Generation Non-Viral Delivery Systems for RNA Delivery?

  • Hamideh Parhiz Research Assistant, Professor of Medicine , University of Pennsylvania
  • Patrick Baumhof Senior Vice President of Technology , CureVac
  • Shawn Davis Executive Director, Drug Delivery , AstraZeneca
  • Mohamed ElSayed Chief Technical Officer, RVAC Medicines
  • Muthiah Manoharan Oligonucleotide Chemist for Delivery of Nucleic Acid Therapeutics , Alnylam Pharmaceuticals

9:30 am Delivery Approaches for Next Generation RNA Therapeutics

  • Heinrich Haas Vice President Formulation & Drug Delivery , BioNTech

10:00 am mRNA Therapeutics for Treatment of Liver Fibrosis

10:30 am Morning Break & Speed Networking

Novel LNP & Alternative Technologies to Advance Non-Viral RNA Delivery

11:30 am Targeted LNP-mRNA Platform for In Vivo Cellular Reprogramming

  • Hamideh Parhiz Research Assistant, Professor of Medicine , University of Pennsylvania

12:00 pm Next Generation mRNA LNPs for Liver Delivery

  • Ashish Sarode Associate Director Delivery & Formulation, Sanofi

12.30am Networking Lunch

1:30 pm Development & Delivery of RNA-Based Therapeutics for Breast Cancer

2:00 pm Tiba’s RNABL™ Platform: An Alternative to Conventional Lipid-Based Delivery Systems

2:30 pm Roundtable Discussion: The interface of RNA modality/particle with delivery systems: How the two should work together towards durable, effective & targeted therapies?

3:15 pm Afternoon Networking Break & Poster Session

Latest Design Improvements of Non-Viral Delivery Systems for Oligonucleotides

4:00 pm Polypeptide Nanoparticle (PNP) & Peptide Docking Vehicle (PDoV) for siRNA Delivery

  • Xiaoyong Lu Director of Chemistry & Oligonucleotide Delivery , Sirnaomics

4:30 pm Nanoparticle Single-Cell Multiomic Readouts Reveal that Cell Heterogeneity Influences Lipid Nanoparticle-Mediated mRNA Delivery

5:00 pm Chair’s Closing Remarks & End of Conference Day One